{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T21:10:47Z","timestamp":1722546647542},"reference-count":27,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2020.8474","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T12:00:30Z","timestamp":1580126430000},"source":"Crossref","is-referenced-by-count":8,"title":["Acquired angioedema induced by angiotensin\u2011converting enzyme inhibitors \u2011 experience of a hospital\u2011based allergy center"],"prefix":"10.3892","author":[{"given":"Polliana","family":"Leru","sequence":"first","affiliation":[{"name":"Family Medicine Department, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vlad","family":"Anton","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Colentina Clinical Hospital, 020125 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corina","family":"Bocsan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Clinical Pharmacology, \u2018Iuliu Ha\u021bieganu\u2019 University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Muntean","sequence":"additional","affiliation":[{"name":"Department of Immunology and Allergology, \u2018Iuliu Ha\u021bieganu\u2019 University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Boda","sequence":"additional","affiliation":[{"name":"Dermatology Research Laboratory, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2020,1,27]]},"reference":[{"key":"key20200713004425_b1-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrd2354","article-title":"Antihypertensive therapies","volume":"6","author":"Smith","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"key20200713004425_b2-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1161\/CIRCULATIONAHA.105.542290","article-title":"Antihypertensive medication use among US adults with hypertension","volume":"113","author":"Gu","year":"2006","journal-title":"Circulation"},{"key":"key20200713004425_b3-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3949\/ccjm.69.5.433","article-title":"ACE inhibitors vs ARBs: Is one class better for heart failure","volume":"69","author":"Dunlap","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"key20200713004425_b4-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1001\/archinte.164.8.910","article-title":"Angioedema associated with angiotensin-converting enzyme inhibitor use: Outcome after switching to a different treatment","volume":"164","author":"Cicardi","year":"2004","journal-title":"Arch Intern Med"},{"key":"key20200713004425_b5-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1081-1206(10)60594-7","article-title":"Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department","volume":"100","author":"Banerji","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key20200713004425_b6-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJM200208223470820","article-title":"Bradykinin-mediated angioedema","volume":"347","author":"Nussberger","year":"2002","journal-title":"N Engl J Med"},{"key":"key20200713004425_b7-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2753.2003.00484.x","article-title":"An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors","volume":"10","author":"Morimoto","year":"2004","journal-title":"J Eval Clin Pract"},{"key":"key20200713004425_b8-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1365-2222.2009.03323.x","article-title":"Angiotensin converting enzyme inhibitor induced angio-oedema: A review of the pathophysiology and risk factors","volume":"40","author":"Hoover","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"key20200713004425_b9-etm-0-0-8474","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s40521-019-0203-y","article-title":"Current treatment of Angioedema induced by ACE inhibitors","volume":"6","author":"Terreehorst","year":"2019","journal-title":"Curr Treat Options Allergy"},{"key":"key20200713004425_b10-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1445-5994.1996.tb00624.x","article-title":"Epidemiological study of angioedema and ACE inhibitors","volume":"26","author":"Gabb","year":"1996","journal-title":"Aust N Z J Med"},{"key":"key20200713004425_b11-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/all.12380","article-title":"HAWK under the patronage of EAACI (European Academy of Allergy and Clinical Immunology): Classification, diagnosis, and approach to treatment for angioedema: Consensus report from the Hereditary Angioedema International Working Group","volume":"69","author":"Cicardi","year":"2014","journal-title":"Allergy"},{"key":"key20200713004425_b12-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000368404","article-title":"Diagnosis and treatment of bradykinin-mediated angioedema: Outcomes from an angioedema expert consensus meeting","volume":"165","author":"Craig","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"key":"key20200713004425_b13-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3892\/etm.2018.6982","article-title":"Isolated angioedema: An overview of clinical features and etiology (Review)","volume":"17","author":"Nedelea","year":"2019","journal-title":"Exp Ther Med"},{"key":"key20200713004425_b14-etm-0-0-8474","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0162-3109(99)00107-1","article-title":"Angioedema due to angiotensin-converting enzyme inhibitors","volume":"44","author":"Agostoni","year":"1999","journal-title":"Immunopharmacology"},{"key":"key20200713004425_b15-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1503\/cmaj.060535","article-title":"Angioedema without urticaria: A large clinical survey","volume":"175","author":"Zingale","year":"2006","journal-title":"CMAJ"},{"key":"key20200713004425_b16-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1378\/chest.128.2.976","article-title":"Are physicians aware of the side effects of angiotensin-converting enzyme inhibitors?: A questionnaire survey in different medical categories","volume":"128","author":"Lombardi","year":"2005","journal-title":"Chest"},{"issue":"18","key":"key20200713004425_b17-etm-0-0-8474","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-019-0259-6","article-title":"Adverse drug reaction classification by health professionals: Appropriate discrimination between allergy and intolerance?","volume":"9","author":"Shakib","year":"2019","journal-title":"Clin Transl Allergy"},{"issue":"16","key":"key20200713004425_b18-etm-0-0-8474","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-10-16","article-title":"Drug allergies in primary care practice in Romania: A questionnaire-based survey","volume":"10","author":"Leru","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"key20200713004425_b19-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/all.12362","article-title":"Angioedema is not just \u2018deep urticaria\u2019 but an entity of its own","volume":"69","author":"Aberer","year":"2014","journal-title":"Allergy"},{"key":"key20200713004425_b20-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2165\/00002018-200124080-00004","article-title":"Drug-induced angioedema without urticaria","volume":"24","author":"Agostoni","year":"2001","journal-title":"Drug Saf"},{"issue":"14","key":"key20200713004425_b21-etm-0-0-8474","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-6-14","article-title":"Acquired angioedema","volume":"6","author":"Cicardi","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"key":"key20200713004425_b22-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1398-9995.1997.tb01024.x","article-title":"Angiotensin-converting enzyme inhibitor-induced angioedema: Late onset, irregular course, and potential role of triggers","volume":"52","author":"Schiller","year":"1997","journal-title":"Allergy"},{"issue":"pii: bcr2016214364","key":"key20200713004425_b23-etm-0-0-8474","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-214364","article-title":"Life-threatening angio-oedema after the first dose of an ACE inhibitor-not an anaphylactic reaction","volume":"2016","author":"Krogh Nielsen","year":"2016","journal-title":"BMJ Case Rep"},{"key":"key20200713004425_b24-etm-0-0-8474","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1520\/JFS15129J","article-title":"Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease","volume":"46","author":"Dean","year":"2001","journal-title":"J Forensic Sci"},{"key":"key20200713004425_b25-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.amjcard.2012.03.034","article-title":"Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors","volume":"110","author":"Makani","year":"2012","journal-title":"Am J Cardiol"},{"key":"key20200713004425_b26-etm-0-0-8474","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1136\/bmj.38803.528113.55","article-title":"Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine","volume":"332","author":"McDowell","year":"2006","journal-title":"BMJ"},{"issue":"69","key":"key20200713004425_b27-etm-0-0-8474","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-018-0274-5","article-title":"Nine year follow-up of a rare case of angioedema due to acquired C1-inhibitor deficiency with late onset and good response to attenuated androgen","volume":"14","author":"Leru","year":"2018","journal-title":"Allergy Asthma Clin Immunol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T23:44:31Z","timestamp":1594597471000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2020.8474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":27,"URL":"https:\/\/doi.org\/10.3892\/etm.2020.8474","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,27]]}}}